0000950170-24-061758.txt : 20240517 0000950170-24-061758.hdr.sgml : 20240517 20240517164146 ACCESSION NUMBER: 0000950170-24-061758 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conley Emily CENTRAL INDEX KEY: 0001907812 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 24960557 MAIL ADDRESS: STREET 1: C/O NUVALENT, INC. STREET 2: ONE BROADWAY 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 ownership.xml 4 X0508 4 2024-05-15 0001861560 Nuvalent, Inc. NUVL 0001907812 Conley Emily C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 true false false false true Class A Common Stock 2024-05-15 4 M false 1667 9.36 A 1675 D Class A Common Stock 2024-05-15 4 M false 3333 13.79 A 5008 D Class A Common Stock 2024-05-15 4 S false 5000 69.09 D 8 D Stock Option (Right to Buy) 9.36 2024-05-15 4 M false 1667 0 D 2032-06-16 Class A Common Stock 1667 0 D Stock Option (Right to Buy) 13.79 2024-05-15 4 M false 3333 0 D 2032-02-02 Class A Common Stock 3333 36667 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.69 to $69.17, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. This option was fully vested and exercisable. The shares underlying this option have vested or shall vest in equal monthly installments over the three years following February 2, 2022, subject to continued service to Nuvalent, Inc. through the applicable vesting date. /s/ Nathan McConarty, attorney-in-fact 2024-05-17